Skip to Content

Tysabri Prices, Coupons and Patient Assistance Programs

Tysabri (natalizumab) is a member of the selective immunosuppressants drug class and is commonly used for Crohn's Disease - Maintenance and Multiple Sclerosis.

Tysabri Prices

This Tysabri price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Tysabri intravenous concentrate (300 mg/15 mL) is around $6,273 for a supply of 15 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Intravenous Concentrate

300 mg/15 mL Tysabri intravenous concentrate
from $6,272.56 for 15 milliliters
Quantity Per unit Price
15 milliliters $418.17 $6,272.56

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 63,000 pharmacies nationwide.


Tysabri Coupons and Rebates

Tysabri offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Patient Assistance Programs for Tysabri

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: HealthWell Foundation Copay Program

Elligibility requirements:

  1. May have insurance
  2. Varies
  3. Medically appropriate condition/diagnosis
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.

Applicable drugs:

  • Tysabri (natalizumab)

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Tysabri (natalizumab)

Provider: Good Days Program

Elligibility requirements:

  1. Not specified
  2. Not disclosed
  3. Not specified
  4. US residency requirements are not specified.
  5. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.

Applicable drugs:

  • Tysabri (natalizumab)

Provider: The Free Drug Program

Elligibility requirements:

  1. Must be uninsured or underinsured
  2. Not disclosed
  3. Relapsing form of MS
  4. The patient must also be residing in the US.
  5. Patients will be referred to a financial assistance counselor. Decisions made on a case by case basis. Program assistance can range from a temporary need up to a 1 year enrollment period. For Avonex, Tecfidera and Plegridy: up to a 90-day supply is sent to the doctor's office or the patient's home. For Tysabri: a one month supply is sent to the doctor's office or site of care for administration of the infusion. Insurance benefits, claims assistance and/or other reimbursement help is offered.

Applicable drugs:

  • Tysabri (natalizumab) Vial; Single-Use
Hide